PAVmed (PAVM) Other Non-Current Liabilities (2017 - 2026)

PAVmed (PAVM) posted quarterly Other Non-Current Liabilities of $6.9 million for Q3 2025, up 1.47% quarter-over-quarter from $6.8 million in Q2 2025.

PAVmed (PAVM) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends

PAVmed's Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $6.9 million for Q3 2025.

In Q3 2025, Other Non-Current Liabilities changed N/A year-over-year to $6.9 million; the TTM figure through Sep 2025 stood at $6.9 million (changed N/A YoY), while the FY2024 annual figure was $29.1 million, down 34.16% from the prior year.
Other Non-Current Liabilities for Q3 2025 stood at $6.9 million, up from $6.8 million in the prior quarter.
The five-year high for Other Non-Current Liabilities was $45.5 million in Q1 2024, with the low at $291000.0 in Q3 2023.
The 4-year median for Other Non-Current Liabilities is $31.6 million (2022), against an average of $26.8 million.
Peak annual rise in Other Non-Current Liabilities reached 804.08% in 2023, while the deepest fall reached 99.18% in 2023.
PAVmed's Other Non-Current Liabilities stood at $33.6 million in 2022, then jumped by 31.35% to $44.2 million in 2023, then sank by 34.16% to $29.1 million in 2024, then sank by 76.29% to $6.9 million in 2025.
Business Quant data shows PAVM's Other Non-Current Liabilities at $6.9 million in Q3 2025, $6.8 million in Q2 2025, and $6.6 million in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	PAVmed	32.48 Mn	28.69 Mn	-89,000.00

Download Data